PMID- 16526951 OWN - NLM STAT- MEDLINE DCOM- 20060424 LR - 20240412 IS - 1471-2350 (Electronic) IS - 1471-2350 (Linking) VI - 7 DP - 2006 Mar 9 TI - On the Wegener granulomatosis associated region on chromosome 6p21.3. PG - 21 AB - BACKGROUND: Wegener granulomatosis (WG) belongs to the heterogeneous group of systemic vasculitides. The multifactorial pathophysiology of WG is supposedly caused by yet unknown environmental influence(s) on the basis of genetic predisposition. The presence of anti-neutrophil cytoplasmic antibodies (ANCA) in the plasma of patients and genetic involvement of the human leukocyte antigen system reflect an autoimmune background of the disease. Strong associations were revealed with WG by markers located in the major histocompatibility complex class II (MHC II) region in the vicinity of human leukocyte antigen (HLA)-DPB1 and the retinoid X receptor B (RXRB) loci. In order to define the involvement of the 6p21.3 region in WG in more detail this previous population-based association study was expanded here to the respective 3.6 megabase encompassing this region on chromosome 6. The RXRB gene was analysed as well as a splice-site variation of the butyrophilin-like (BTNL2) gene which is also located within the respective region. The latter polymorphism has been evaluated here as it appears as a HLA independent susceptibility factor in another granulomatous disorder, sarcoidosis. METHODS: 150-180 German WG patients and a corresponding cohort of healthy controls (n = 100-261) were used in a two-step study. A panel of 94 microsatellites was designed for the initial step using a DNA pooling approach. Markers with significantly differing allele frequencies between patient and control pools were individually genotyped. The RXRB gene was analysed for single strand conformation polymorphisms (SSCP) and restriction fragment length polymorphisms (RFLP). The splice-site polymorphism in the BTNL2 gene was also investigated by RFLP analysis. RESULTS: A previously investigated microsatellite (#1.0.3.7, Santa Cruz genome browser (UCSC) May 2004 Freeze localisation: chr6:31257596-34999883), which was used as a positive control, remained associated throughout the whole two-step approach. Yet, no additional evidence for association of other microsatellite markers was found in the entire investigated region. Analysis of the RXRB gene located in the WG associated region revealed associations of two variations (rs10548957 pallelic = 0.02 and rs6531 pallelic = 5.20 x 10-5, OR = 1.88). Several alleles of markers located between HLA-DPB1, SNP rs6531 and microsatellite 1.0.3.7 showed linkage disequilibrium with r2 values exceeding 0.10. Significant differences were not demonstrable for the sarcoidosis associated splice-site variation (rs2076530 pallelic = 0.80) in our WG cohort. CONCLUSION: Since a microsatellite flanking the RXRB gene and two intragenic polymorphisms are associated significantly with WG on chromosome 6p21.3, further investigations should be focussed on extensive fine-mapping in this region by densely mapping with additional markers such as SNPs. This strategy may reveal even deeper insights into the genetic contributions of the respective region for the pathogenesis of WG. FAU - Szyld, Pawel AU - Szyld P AD - Human Genetics, Ruhr-University, Bochum, Germany. szyld@list.pl FAU - Jagiello, Peter AU - Jagiello P FAU - Csernok, Elena AU - Csernok E FAU - Gross, Wolfgang L AU - Gross WL FAU - Epplen, Joerg T AU - Epplen JT LA - eng PT - Journal Article DEP - 20060309 PL - England TA - BMC Med Genet JT - BMC medical genetics JID - 100968552 RN - 0 (BTNL2 protein, human) RN - 0 (Butyrophilins) RN - 0 (Membrane Glycoproteins) RN - 0 (Retinoid X Receptor beta) SB - IM MH - Butyrophilins MH - Chromosome Mapping MH - *Chromosomes, Human, Pair 6 MH - Granulomatosis with Polyangiitis/*genetics MH - Humans MH - Linkage Disequilibrium MH - Membrane Glycoproteins/*genetics MH - Microsatellite Repeats MH - Retinoid X Receptor beta/*genetics PMC - PMC1431512 EDAT- 2006/03/11 09:00 MHDA- 2006/04/25 09:00 PMCR- 2006/03/09 CRDT- 2006/03/11 09:00 PHST- 2005/07/29 00:00 [received] PHST- 2006/03/09 00:00 [accepted] PHST- 2006/03/11 09:00 [pubmed] PHST- 2006/04/25 09:00 [medline] PHST- 2006/03/11 09:00 [entrez] PHST- 2006/03/09 00:00 [pmc-release] AID - 1471-2350-7-21 [pii] AID - 10.1186/1471-2350-7-21 [doi] PST - epublish SO - BMC Med Genet. 2006 Mar 9;7:21. doi: 10.1186/1471-2350-7-21.